Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yann Parc

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 27, 2023
Features of colorectal adenomas among young patients with Lynch syndrome according to path_MMR: Results from the PRED-IdF registryHadrien Alric, Elise Coffin, Celine Lekhal, et al.
European Journal of Human Genetics : EJHG|July 3, 2026
Correction: follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: data from the PRED-IdF networkMaxime Rémond, Youenn Drouet, Antoine Dardenne, et al.
Plos Medicine|May 24, 2013
Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic valueLaetitia Marisa, Aurélien de Reyniès, Alex Duval, et al.
Annals of Surgery|October 22, 2019
Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter TrialJérémie H Lefèvre, Laurent Mineur, Marine Cachanado, et al.
Annals of Surgery|April 9, 2011
Outcome and cost analysis of sacral nerve modulation for treating urinary and/or fecal incontinenceAnne-Marie Leroi, Xavier Lenne, Benoît Dervaux, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 18, 2018
Identification of Positively and Negatively Selected Driver Gene Mutations Associated With Colorectal Cancer With Microsatellite InstabilityVincent Jonchere, Laetitia Marisa, Malorie Greene, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)Jérémie H Lefevre, Laurent Mineur, Salma Kotti, et al.
Journal of the National Cancer Institute|September 20, 2017
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon TumorsLaetitia Marisa, Magali Svrcek, Ada Collura, et al.
Diseases of the Colon and Rectum|November 7, 2024
Final Results of the GRECCAR-6 Trial on Waiting Period Following Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer: 5 Years of Follow-upMaxime K Collard, Laurent Mineur, Célia Nekrouf, et al.
Nature Medicine|September 28, 2011
Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosisCoralie Dorard, Aurélie de Thonel, Ada Collura, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 27, 2023
Features of colorectal adenomas among young patients with Lynch syndrome according to path_MMR: Results from the PRED-IdF registryHadrien Alric, Elise Coffin, Celine Lekhal, et al.
European Journal of Human Genetics : EJHG|July 3, 2026
Correction: follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: data from the PRED-IdF networkMaxime Rémond, Youenn Drouet, Antoine Dardenne, et al.
Plos Medicine|May 24, 2013
Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic valueLaetitia Marisa, Aurélien de Reyniès, Alex Duval, et al.
Annals of Surgery|October 22, 2019
Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter TrialJérémie H Lefèvre, Laurent Mineur, Marine Cachanado, et al.
Annals of Surgery|April 9, 2011
Outcome and cost analysis of sacral nerve modulation for treating urinary and/or fecal incontinenceAnne-Marie Leroi, Xavier Lenne, Benoît Dervaux, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 18, 2018
Identification of Positively and Negatively Selected Driver Gene Mutations Associated With Colorectal Cancer With Microsatellite InstabilityVincent Jonchere, Laetitia Marisa, Malorie Greene, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)Jérémie H Lefevre, Laurent Mineur, Salma Kotti, et al.
Journal of the National Cancer Institute|September 20, 2017
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon TumorsLaetitia Marisa, Magali Svrcek, Ada Collura, et al.
Diseases of the Colon and Rectum|November 7, 2024
Final Results of the GRECCAR-6 Trial on Waiting Period Following Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer: 5 Years of Follow-upMaxime K Collard, Laurent Mineur, Célia Nekrouf, et al.
Nature Medicine|September 28, 2011
Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosisCoralie Dorard, Aurélie de Thonel, Ada Collura, et al.
Pageof 15